# Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis

> **NCT07074990** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 46 (actual)

## Conditions studied

- Sepsis at Intensive Care Unit

## Interventions

- **DRUG:** conventional sepsis therapy alone
- **DRUG:** colchicine 500 mcg oral twice daily plus conventional sepsis therapy.

## Key facts

- **NCT ID:** NCT07074990
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07074990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07074990, "Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07074990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*